Abstract
Schizophrenia is characterized by positive, negative, cognitive and mood symptoms. Treatment includes both psychosocial and psychopharmacological interventions. A "primum non nocere" principle is recommended when choosing an antipsychotic for adolescents, who are more vulnerable to many side effects. Rationales for monitoring side effects and switching antipsychotics if needed should be considered. Despite lack of evidence in this age group, adolescents seem to benefit from cognitive behavioural therapy, family interventions and general principals of open dialogue as well as an orientation towards recovery as perceived by patients and parents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literature
American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn (DSM-5™). American Psychiatric Publishing, Washington/London
Correll CU (2010) From receptor pharmacology to improved outcomes: individualizing the selection, dosing, and switching of antipsychotics. Eur Psychiatry 25:12–21
De Hert M, Detraux J, van Winkel R et al (2011) Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol 8:114–126
Gallego JA, Nielsen J, De Hert M, Kane JM, Correll CU (2012) Safety and tolerability of antipsychotic polypharmacy. Expert Opin Drug Saf 11:527–542
McClellan J, Stock S, American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI) (2013) Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry 52:976–990
Murru A, Pacchiarotti I, Nivoli AM, Grande I, Colom F, Vieta E (2011) What we know and what we don’t know about the treatment of schizoaffective disorder. Eur Neuropsychopharmacol 21:680–690
Naber D, Holzbach R, Perro C, Hippius H (1992) Clinical management of clozapine patients in relation to efficacy and side-effects. Br J Psychiatry 160(Suppl 17):54–59
National Institute for Health and Clinical Excellence (2013a) Psychosis and schizophrenia in children and young people. Recognition and management. NICE clinical guideline 155 (http://www.nice.org.uk/cg155)
National Institute for Health and Clinical Excellence (2013b) Quality standard for self-harm. QS34 (http://publications.nice.org.uk/quality-standard-for-selfharm-qs34)
Sassim N, Grohmann R (1988) Adverse drug reactions with clozapine and simultaneous application of benzodiazepines. Pharmacopsychiatry 21:306–307
Schimmelmann BG, Paulus S, Schacht M, Tilgner C, Schulte-Markwort M, Lambert M (2005) Subjective distress related to side effects and subjective well-being in first admitted adolescents with early-onset psychosis treated with atypical antipsychotics. J Child Adolesc Psychopharmacol 15:249–258
Schimmelmann BG, Schmidt SJ, Carbon M, Correll CU (2013a) Treatment of adolescents with early-onset schizophrenia spectrum disorders: in search of a rational, evidence-informed approach. Curr Opin Psychiatry 26:219–230
Schimmelmann BG, Walger P, Schultze-Lutter F (2013b) The significance of at-risk symptoms for psychosis in children and adolescents. Can J Psychiatry 58:32–40
World Health Organization (1996) Multiaxial classification of child and adolescent psychiatric disorders. The ICD – 10 classification of mental and behavioral disorders in children and adolescents. Cambridge University Press, Cambridge
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Wien
About this chapter
Cite this chapter
Schimmelmann, B.G., Mehler-Wex, C., Wewetzer, C. (2014). Schizophrenia. In: Gerlach, M., Warnke, A., Greenhill, L. (eds) Psychiatric Drugs in Children and Adolescents. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1501-5_25
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1501-5_25
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1500-8
Online ISBN: 978-3-7091-1501-5
eBook Packages: MedicineMedicine (R0)